Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 109 clinical trials
T-Lymphocytes for Prevention or Treatment of Viral Infections Following Hematopoietic Stem Cell Transplantation

for infusion to recipients of allogeneic hematopoietic stem cell transplant (HSCT), who are at risk of developing EBV, CMV, adenovirus, HHV6, BKV, JCV and/or HPIV3, or with PCR/culture confirmed

stem cell transplantation
cmv infection
prednisone
parainfluenza
antiviral drugs
  • 54 views
  • 25 Jan, 2021
  • 1 location
Effects of Pulmonary Rehabilitation in Hematopoietic Stem Cell Transplantation Recipients

shown in the literature that inspiratory muscle training in allogeneic hematopoietic stem cell transplant recipients increases functional exercise capacity, inspiratory and expiratory muscle strength

graft versus host disease
fibrosis
hereditary diseases
allogeneic hematopoietic stem cell transplant
immunosuppression
  • 1 views
  • 25 Jan, 2021
  • 1 location
ECT-001 (UM171) Expanded Cord Blood Transplant to Treat High-risk Multiple Myeloma

potential curative treatment remains allogeneic Hematopoietic stem cell transplant (HSCT), as shown by our cohort of 92 newly diagnosed patients who received a sibling tandem auto-allo (HSCT) with an

lenalidomide
graft versus host disease
leukemia
measurable disease
plasma cell leukemia
  • 61 views
  • 05 Feb, 2021
  • 3 locations
Blinatumomab and Nivolumab With or Without Ipilimumab in Treating Patients With Poor-Risk Relapsed or Refractory CD19+ Precursor B-Lymphoblastic Leukemia

This phase I trial studies the side effects and best dose of blinatumomab when given with nivolumab alone or nivolumab and ipilimumab in treating patients with poor-risk CD19+ precursor B-lymphoblastic leukemia that has come back after a period of improvement (relapsed) or has not responded to treatment (refractory). Immunotherapy with …

  • 43 views
  • 30 Jan, 2021
  • 3 locations
Administration of Donor Multi TAA-Specific T Cells for AML or MDS (ADSPAM)

myelodysplastic syndrome (MDS) which has come back, or may come back, or has not gone away after standard treatment, including an allogeneic hematopoietic stem cell transplant (HSCT). The investigators

aml/mds
hodgkin's disease
lymphoma
cancer
residual tumor
  • 54 views
  • 24 Jan, 2021
  • 2 locations
Len/Dex/DLI in Relapsed Multiple Myeloma After Allogeneic Stem Cell Transplant

Multiple Myeloma (MM) is a morbid disease which can only be cured with an allogeneic hematopoietic stem cell transplant (HSCT). Approximately 50% of allotransplanted patients will relapse, with

lenalidomide
graft versus host disease
measurable disease
dexamethasone
bone marrow procedure
  • 31 views
  • 03 Feb, 2021
  • 3 locations
T Cells Expressing a Fully-Human Anti-CD30 Chimeric Antigen Receptor for Treating CD30-Expressing Lymphomas

never had an allogeneic hematopoietic stem cell transplant as well as patients who have had a 9/10 or 10/10 HLA-matched sibling or a 9/10 or 10/10 HLAmatched unrelated donor hematopoietic stem cell

cancer
peripheral t-cell lymphoma
lymphoma
ct scan
ejection fraction
  • 1 views
  • 27 Jan, 2021
  • 1 location
Denosumab in Treating Patients With Bone Loss Due to Donor Stem Cell Transplant

This phase II trial studies the side effects of denosumab and to see how well it works in treating patients with bone loss who have received a donor stem cell transplant. Patients receiving a donor stem cell transplant may experience accelerated bone loss and an increase risk of bone fractures, …

bone mineral density
x-ray absorptiometry
RANKL
dual-energy x-ray absorptiometry
osteoporosis
  • 53 views
  • 04 Feb, 2021
  • 2 locations
Busulfan and Cyclophosphamide Followed By ALLO BMT

This is a treatment guideline to allow routine clinical data to be collected and maintained in Oncore (clinical database) and the University of Minnesota Blood and Marrow Database as part of the historical database maintained by the department.

myeloid leukemia
ejection fraction
remission
bone marrow transplant
lymphocyte immune globulin
  • 22 views
  • 24 Jan, 2021
  • 1 location
Red Cell Half Life Determination in Patients With and Without Sickle Cell Disease

Background Sickle cell disease (SCD) is an inherited blood disorder. It results from a single genetic change (mutation) in red blood cells (RBCs). RBCs are the cells that carry oxygen to the body. In people with SCD, some RBCs are abnormal and die early. This leaves a shortage of healthy …

hemoglobin s
blood disorder
anemia
sickle cell trait
bone marrow transplant
  • 0 views
  • 07 Mar, 2021
  • 1 location